The trial results are critical, as it brings Eli Lilly's pill one step closer to becoming a new, needle-free alternative for ...
Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to ...
As FDA shortages lift, patients and physicians explore new options for continued treatment with compounded GLP-1 medications.
Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...
Eli Lilly launched its weight loss drug Mounjaro in India. According to the company, the injection is supposed to be taken ...
Starting at Rs 3,500 per injection, with a monthly cost of up to Rs 14,000, Mounjaro enters India’s growing diabetes and ...
The global weight-loss drug market is expected to reach $150 billion in the next decade. By 2026, semaglutide (the active ...